Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates

Royalty Pharma (RPRX) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.85 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 1.05%. A quarter ago, it was expected that this company would post earnings of $0.96 per share when it actually produced earnings of $0.98, delivering a surprise of 2.08%. Over the last four quarters, the company h ...